CASTLE BIOSCIENCES INC
FRIENDSWOOD, TX · Founded 2007 · CIK 0001447362 · Medtech · Public
Genomic profiling tests for cancer risk stratification and prognosis
castlebiosciences.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $56M
- 12 Form D · Jul 2019
- 86 months since last filing
- Contracts
- $33K
- 5 awards · Veterans Affairs, Defense
- #590 of 4531 in medtech
- Patents
- 40
- 5 granted · 35 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓200920112013201520172019
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,124,999 | |
| Private capital raised | Form D · SEC | $1,343,689 | |
| Private capital raised | Form D · SEC | $1,508,000 | |
| Private capital raised | Form D · SEC | $1,000,000 | |
| Private capital raised | Form D · SEC | $1,000,000 | |
| Private capital raised | Form D · SEC | $1,501,000 | |
| Private capital raised | Form D · SEC | $7,518,000 | |
| Private capital raised | Form D · SEC | $11,700,000 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf Melanoma Analysis | $7,918 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf Melanoma Analysis | $7,918 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf Cancer Screening | $8,640 | |
| Federal contract | Department of Defense · Igf::ct::igf Decisiondx-um Ffpe Test | $8,640 | |
| Private capital raised | Form D · SEC | $5,475,746 | |
| Private capital raised | Form D · SEC | $5,058,036 | |
| Private capital raised | Form D · SEC | $8,720,375 | |
| Private capital raised | Form D · SEC | $10,000,000 |
Federal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 587 | ZAIPUT FLOW TECHNOLOGIES LLC | $36K | — |
| 588 | SHEEHAN MEDICAL LLC | $35K | — |
| 589 | SHAPE MEMORY MEDICAL INC | $35K | $56M |
| 590 | CASTLE BIOSCIENCES INC | $33K | $56M |
| 591 | nPulse Technologies, Inc. | $33K | $2.9M |
| 592 | Atlas Spine, Inc. | $33K | $3.5M |
| 593 | LIGHTSENSE TECHNOLOGY INC | $32K | $20K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Bonnie AndersonDirector
- Mara AspinallDirector
- Daniel BradburyDirector
- G. ColeDirector
- Joseph Cook, IIIDirector
- Joe Cook, Jr.Director
- Joseph Cook, Jr.Director
- David Kabakoff, Ph.D.Director
- Garheng KongDirector
- Derek MaetzoldDirector · Executive Officer · Promoter
- Federico Monzon, M.D., FCAPExecutive Officer
- Bernhard SpiessExecutive Officer
- Frank StokesExecutive Officer
Patents
- Methods Of Diagnosing And Treating Patients With Cutaneous Squamous Cell Carcinomaapplication
- Methods Of Diagnosing And Treating Patients With Cutaneous Squamous Cell Carcinomaapplication
- Diagnostic Test For Predicting Metastasis And Recurrence In Cutaneous Melanomaapplication
- Diagnostic Test For Predicting Metastasis And Recurrence In Cutaneous Melanomaapplication
- Methods Of Diagnosing And Treating Patients With Cutaneous Squamous Cell Carcinomaapplication
- Diagnostic Test For Predicting Metastasis And Recurrence In Cutaneous Melanomagranted
- Methods Of Diagnosing And Treating Patients With Cutaneous Squamous Cell Carcinomaapplication
- Methods Of Diagnosing And Treating Patients With Cutaneous Squamous Cell Carcinomaapplication
- Methods Of Diagnosing And Treating Patients With Cutaneous Squamous Cell Carcinomaapplication
- Methods Of Diagnosing And Treating Patients With Cutaneous Squamous Cell Carcinomagranted
- Methods Of Diagnosing And Treating Patients With Cutaneous Squamous Cell Carcinomagranted
- Determining Prognosis and Treatment based on Clinical-Pathologic Factors and Continuous Multigene-Expression Profile Scoresapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.